Theradiag SA - Asset Resilience Ratio

Latest as of June 2025: 15.59%

Theradiag SA (ALTHE) has an Asset Resilience Ratio of 15.59% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Theradiag SA (ALTHE) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€1.80 Million

≈ $2.10 Million USD Cash + Short-term Investments

Total Assets

€11.55 Million

≈ $13.50 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2023)

This chart shows how Theradiag SA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Theradiag SA balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Theradiag SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Theradiag SA strategic investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.80 Million	15.59%
Total Liquid Assets	€1.80 Million	15.59%

Asset Resilience Insights

Good Liquidity Position: Theradiag SA maintains a healthy 15.59% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Theradiag SA Industry Peers by Asset Resilience Ratio

Compare Theradiag SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%
Profound Medical Corp TO:PRN	Medical Devices	67.66%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Epitomee Medical Ltd TA:EPIT	Medical Devices	0.24%
Cleo Diagnostics Ltd AU:COV	Medical Devices	94.64%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%

Annual Asset Resilience Ratio for Theradiag SA (2010–2023)

The table below shows the annual Asset Resilience Ratio data for Theradiag SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	-0.12%	€-21.82K ≈ $-25.51K	€18.66 Million ≈ $21.82 Million	-0.34pp
2022-12-31	0.22%	€31.10K ≈ $36.36K	€13.94 Million ≈ $16.30 Million	-0.04pp
2021-12-31	0.26%	€31.10K ≈ $36.36K	€11.83 Million ≈ $13.83 Million	-0.03pp
2020-12-31	0.29%	€31.10K ≈ $36.36K	€10.55 Million ≈ $12.33 Million	0.00pp
2019-12-31	0.30%	€31.10K ≈ $36.36K	€10.51 Million ≈ $12.29 Million	-0.03pp
2018-12-31	0.33%	€31.10K ≈ $36.36K	€9.56 Million ≈ $11.18 Million	+0.10pp
2017-12-31	0.23%	€31.10K ≈ $36.36K	€13.77 Million ≈ $16.10 Million	-33.97pp
2016-12-31	34.19%	€5.03 Million ≈ $5.88 Million	€14.71 Million ≈ $17.20 Million	+14.41pp
2015-12-31	19.78%	€1.83 Million ≈ $2.14 Million	€9.26 Million ≈ $10.82 Million	+1.29pp
2014-12-31	18.50%	€1.53 Million ≈ $1.79 Million	€8.28 Million ≈ $9.69 Million	+17.44pp
2013-12-31	1.06%	€31.10K ≈ $36.36K	€2.94 Million ≈ $3.44 Million	+0.08pp
2012-12-31	0.97%	€31.10K ≈ $36.36K	€3.20 Million ≈ $3.74 Million	-23.96pp
2011-12-31	24.93%	€575.16K ≈ $672.42K	€2.31 Million ≈ $2.70 Million	+24.66pp
2010-12-31	0.27%	€10.60K ≈ $12.39K	€3.91 Million ≈ $4.57 Million	--

pp = percentage points

About Theradiag SA

PA:ALTHE France Medical Devices

Market Cap

$48.63 Million

€41.59 Million EUR

Market Cap Rank

#23147 Global

#359 in France

Share Price

€0.70

Change (1 day)

-0.56%

52-Week Range

€0.43 - €0.87

All Time High

€8.20